- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ADAC announces new CT simulation package
ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package. SmartSim is an integrated CT simulation and
ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package.
SmartSim is an integrated CT simulation and radiation therapy planning package that speeds up the radiation treatment planning process. The SmartSim package is used with ADACs Pinnacle3 radiation therapy planning system.
SmartSim software reconstructs data gathered from CT scans into 3-D images and digitally reconstructed radiographs. This allows radiation oncologists to more accurately pinpoint the location, size, and shape of tumors. Clinicians are then able to determine optimal radiation beam placements to treat cancerous cells while minimizing the risk to nearby healthy tissue, the firm reports. The program uses a single database for simulation and planning.
Shipments of SmartSim began this month. The company expects the market for CT stimulation products to reach about $100 million this year as radiation oncologists use the technology in place of conventional x-ray simulation.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
